Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Rituximab shows promise in management of neuropsychiatric SLE

02 Jul 2024 bởi

Treatment with rituximab (RTX) in patients with moderate-to-severe neuropsychiatric (NP) systemic lupus erythematosus (SLE) appears to result in some improvements and to contribute to the use of a much lower steroid dose at 6 months, suggests a study presented at EULAR 2024.

02 Jul 2024

Psychotic disorders entail long-term management

01 Jul 2024

A long-term healthcare plan appears necessary for people with psychotic disorders to detect and respond to changes in the trajectory of their disease course, suggests a study.

01 Jul 2024

Cognitive remediation delivers sustained improvement in schizophrenia

30 Jun 2024

People with schizophrenia may benefit from cognitive remediation which offers durable improvements in both cognition and psychosocial functioning, as shown in a study.

30 Jun 2024

Depressive symptoms common in hypogonadal men, TRT helps

27 Jun 2024

Depressive symptoms are likely to occur in middle-aged and older men with hypogonadism, but low-grade persistent depressive disorder (LG-PDD) is rare, according to a study.

27 Jun 2024

Anxiety and depression prevalent in primary care

21 Jun 2024 bởi

The presence of coexisting clinical depression and anxiety (DA) is not uncommon in the primary care setting, particularly among younger individuals, patients with diabetes, and women, a Singapore study has shown.

21 Jun 2024

One-fifth of people attempting suicide have no prior mental disorders

11 Jun 2024 bởi

One in five individuals who attempt suicide do not have a history of psychiatric disorders, a cross-sectional study has shown.

11 Jun 2024

Autism’s skewed gender ratio explained

11 Jun 2024 bởi

The skewed gender ratio in autism spectrum disorder (ASD) may be explained by differences in heritability in males and females, an international study has found.

11 Jun 2024

Original New Drug Application Approvals by US FDA (16-31 May 2024)

10 Jun 2024

New drug applications approved by US FDA as of 16-31 May 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

10 Jun 2024

Increased practice of Chinese calligraphy strengthens brain network in older adults

07 Jun 2024 bởi

Increased practice of Chinese calligraphy strengthens brain network in older individuals who already practice the cognitive activity regularly and experienced subjective cognitive decline (SCD), a two-arm, parallel-design, assessor-blind, randomized controlled trial conducted by the Chinese University of Hong Kong (CUHK) has found.

07 Jun 2024

FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients

05 Jun 2024 bởi

Patients with postacute COVID-19 syndrome (PACS) may benefit from faecal microbiota transplantation (FMT) treatment, which helps reduce anxiety and improve sleep quality, suggests a study.

05 Jun 2024